nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—Hyporeflexia—Epirubicin—liver cancer	0.00922	0.0139	CcSEcCtD
Estazolam—Hyporeflexia—Doxorubicin—liver cancer	0.00853	0.0128	CcSEcCtD
Estazolam—Pain in extremity—Sorafenib—liver cancer	0.00823	0.0124	CcSEcCtD
Estazolam—Clonazepam—NAT2—liver cancer	0.00819	0.375	CrCbGaD
Estazolam—Mood swings—Sorafenib—liver cancer	0.0078	0.0117	CcSEcCtD
Estazolam—Dry skin—Sorafenib—liver cancer	0.00755	0.0113	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00741	0.0111	CcSEcCtD
Estazolam—Nasopharyngitis—Sorafenib—liver cancer	0.00736	0.0111	CcSEcCtD
Estazolam—Gastritis—Sorafenib—liver cancer	0.00729	0.0109	CcSEcCtD
Estazolam—Vaginal discharge—Epirubicin—liver cancer	0.00689	0.0103	CcSEcCtD
Estazolam—Weight decreased—Sorafenib—liver cancer	0.00644	0.00967	CcSEcCtD
Estazolam—Vaginal discharge—Doxorubicin—liver cancer	0.00637	0.00958	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00629	0.00945	CcSEcCtD
Estazolam—Neuropathy peripheral—Sorafenib—liver cancer	0.00622	0.00934	CcSEcCtD
Estazolam—Hypokinesia—Epirubicin—liver cancer	0.00621	0.00933	CcSEcCtD
Estazolam—Hyperventilation—Epirubicin—liver cancer	0.00609	0.00915	CcSEcCtD
Estazolam—Epistaxis—Sorafenib—liver cancer	0.00598	0.00899	CcSEcCtD
Estazolam—Nystagmus—Epirubicin—liver cancer	0.00587	0.00881	CcSEcCtD
Estazolam—Laryngitis—Epirubicin—liver cancer	0.00581	0.00874	CcSEcCtD
Estazolam—Hypokinesia—Doxorubicin—liver cancer	0.00574	0.00863	CcSEcCtD
Estazolam—Hyperventilation—Doxorubicin—liver cancer	0.00563	0.00847	CcSEcCtD
Estazolam—Neuritis—Epirubicin—liver cancer	0.00561	0.00843	CcSEcCtD
Estazolam—Scotoma—Epirubicin—liver cancer	0.00552	0.00829	CcSEcCtD
Estazolam—Nystagmus—Doxorubicin—liver cancer	0.00543	0.00816	CcSEcCtD
Estazolam—Erythema multiforme—Sorafenib—liver cancer	0.00538	0.00809	CcSEcCtD
Estazolam—Laryngitis—Doxorubicin—liver cancer	0.00538	0.00808	CcSEcCtD
Estazolam—Tinnitus—Sorafenib—liver cancer	0.00531	0.00798	CcSEcCtD
Estazolam—Flushing—Sorafenib—liver cancer	0.00529	0.00794	CcSEcCtD
Estazolam—Neuritis—Doxorubicin—liver cancer	0.00519	0.0078	CcSEcCtD
Estazolam—Scotoma—Doxorubicin—liver cancer	0.00511	0.00767	CcSEcCtD
Estazolam—Arrhythmia—Sorafenib—liver cancer	0.00509	0.00764	CcSEcCtD
Estazolam—Malnutrition—Sorafenib—liver cancer	0.00496	0.00745	CcSEcCtD
Estazolam—Muscle spasms—Sorafenib—liver cancer	0.00477	0.00716	CcSEcCtD
Estazolam—Thinking abnormal—Epirubicin—liver cancer	0.00458	0.00688	CcSEcCtD
Estazolam—Oliguria—Epirubicin—liver cancer	0.00455	0.00683	CcSEcCtD
Estazolam—Nocturia—Epirubicin—liver cancer	0.00452	0.00679	CcSEcCtD
Estazolam—Syncope—Sorafenib—liver cancer	0.00445	0.00668	CcSEcCtD
Estazolam—Leukopenia—Sorafenib—liver cancer	0.00444	0.00667	CcSEcCtD
Estazolam—Ulcer—Epirubicin—liver cancer	0.00443	0.00666	CcSEcCtD
Estazolam—Loss of consciousness—Sorafenib—liver cancer	0.00436	0.00655	CcSEcCtD
Estazolam—Cough—Sorafenib—liver cancer	0.00433	0.0065	CcSEcCtD
Estazolam—Coordination abnormal—Epirubicin—liver cancer	0.00427	0.00641	CcSEcCtD
Estazolam—Neck pain—Epirubicin—liver cancer	0.00424	0.00637	CcSEcCtD
Estazolam—Thinking abnormal—Doxorubicin—liver cancer	0.00424	0.00636	CcSEcCtD
Estazolam—Myalgia—Sorafenib—liver cancer	0.00422	0.00634	CcSEcCtD
Estazolam—Arthralgia—Sorafenib—liver cancer	0.00422	0.00634	CcSEcCtD
Estazolam—Oliguria—Doxorubicin—liver cancer	0.00421	0.00632	CcSEcCtD
Estazolam—Nocturia—Doxorubicin—liver cancer	0.00418	0.00628	CcSEcCtD
Estazolam—Dry mouth—Sorafenib—liver cancer	0.00413	0.0062	CcSEcCtD
Estazolam—Ulcer—Doxorubicin—liver cancer	0.0041	0.00616	CcSEcCtD
Estazolam—Melaena—Epirubicin—liver cancer	0.00409	0.00615	CcSEcCtD
Estazolam—Shock—Sorafenib—liver cancer	0.00398	0.00598	CcSEcCtD
Estazolam—Coordination abnormal—Doxorubicin—liver cancer	0.00395	0.00593	CcSEcCtD
Estazolam—Neck pain—Doxorubicin—liver cancer	0.00393	0.0059	CcSEcCtD
Estazolam—Melaena—Doxorubicin—liver cancer	0.00379	0.00569	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00369	0.00554	CcSEcCtD
Estazolam—Abnormal vision—Epirubicin—liver cancer	0.00366	0.00549	CcSEcCtD
Estazolam—Mental disability—Epirubicin—liver cancer	0.00364	0.00546	CcSEcCtD
Estazolam—Dyspnoea—Sorafenib—liver cancer	0.00361	0.00542	CcSEcCtD
Estazolam—Lymphadenopathy—Epirubicin—liver cancer	0.00357	0.00536	CcSEcCtD
Estazolam—Dyspepsia—Sorafenib—liver cancer	0.00356	0.00535	CcSEcCtD
Estazolam—Decreased appetite—Sorafenib—liver cancer	0.00352	0.00528	CcSEcCtD
Estazolam—Photosensitivity—Epirubicin—liver cancer	0.00346	0.00521	CcSEcCtD
Estazolam—Pain—Sorafenib—liver cancer	0.00346	0.0052	CcSEcCtD
Estazolam—Constipation—Sorafenib—liver cancer	0.00346	0.0052	CcSEcCtD
Estazolam—Vascular purpura—Epirubicin—liver cancer	0.0034	0.00511	CcSEcCtD
Estazolam—Abnormal vision—Doxorubicin—liver cancer	0.00338	0.00508	CcSEcCtD
Estazolam—Eye pain—Epirubicin—liver cancer	0.00337	0.00506	CcSEcCtD
Estazolam—Mental disability—Doxorubicin—liver cancer	0.00337	0.00506	CcSEcCtD
Estazolam—Gastrointestinal pain—Sorafenib—liver cancer	0.00331	0.00497	CcSEcCtD
Estazolam—Lymphadenopathy—Doxorubicin—liver cancer	0.0033	0.00496	CcSEcCtD
Estazolam—Increased appetite—Epirubicin—liver cancer	0.00324	0.00486	CcSEcCtD
Estazolam—Urticaria—Sorafenib—liver cancer	0.00321	0.00483	CcSEcCtD
Estazolam—Photosensitivity—Doxorubicin—liver cancer	0.00321	0.00482	CcSEcCtD
Estazolam—Abdominal pain—Sorafenib—liver cancer	0.0032	0.0048	CcSEcCtD
Estazolam—Body temperature increased—Sorafenib—liver cancer	0.0032	0.0048	CcSEcCtD
Estazolam—Purpura—Epirubicin—liver cancer	0.00316	0.00474	CcSEcCtD
Estazolam—Vascular purpura—Doxorubicin—liver cancer	0.00315	0.00473	CcSEcCtD
Estazolam—Eye pain—Doxorubicin—liver cancer	0.00312	0.00468	CcSEcCtD
Estazolam—Diplopia—Epirubicin—liver cancer	0.00304	0.00457	CcSEcCtD
Estazolam—Pain in extremity—Epirubicin—liver cancer	0.00304	0.00457	CcSEcCtD
Estazolam—Increased appetite—Doxorubicin—liver cancer	0.003	0.0045	CcSEcCtD
Estazolam—Affect lability—Epirubicin—liver cancer	0.00299	0.0045	CcSEcCtD
Estazolam—Hypersensitivity—Sorafenib—liver cancer	0.00298	0.00448	CcSEcCtD
Estazolam—Purpura—Doxorubicin—liver cancer	0.00292	0.00439	CcSEcCtD
Estazolam—Asthenia—Sorafenib—liver cancer	0.0029	0.00436	CcSEcCtD
Estazolam—Mood swings—Epirubicin—liver cancer	0.00288	0.00433	CcSEcCtD
Estazolam—Pruritus—Sorafenib—liver cancer	0.00286	0.0043	CcSEcCtD
Estazolam—Ataxia—Epirubicin—liver cancer	0.00286	0.0043	CcSEcCtD
Estazolam—Pain in extremity—Doxorubicin—liver cancer	0.00281	0.00423	CcSEcCtD
Estazolam—Diplopia—Doxorubicin—liver cancer	0.00281	0.00423	CcSEcCtD
Estazolam—Dry skin—Epirubicin—liver cancer	0.00279	0.00419	CcSEcCtD
Estazolam—Affect lability—Doxorubicin—liver cancer	0.00277	0.00416	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00274	0.00412	CcSEcCtD
Estazolam—Nasopharyngitis—Epirubicin—liver cancer	0.00272	0.00409	CcSEcCtD
Estazolam—Gastritis—Epirubicin—liver cancer	0.00269	0.00404	CcSEcCtD
Estazolam—Dizziness—Sorafenib—liver cancer	0.00268	0.00402	CcSEcCtD
Estazolam—Mood swings—Doxorubicin—liver cancer	0.00267	0.00401	CcSEcCtD
Estazolam—Ataxia—Doxorubicin—liver cancer	0.00265	0.00398	CcSEcCtD
Estazolam—Asthma—Epirubicin—liver cancer	0.00263	0.00395	CcSEcCtD
Estazolam—Dry skin—Doxorubicin—liver cancer	0.00258	0.00388	CcSEcCtD
Estazolam—Vomiting—Sorafenib—liver cancer	0.00257	0.00386	CcSEcCtD
Estazolam—Rash—Sorafenib—liver cancer	0.00255	0.00383	CcSEcCtD
Estazolam—Dermatitis—Sorafenib—liver cancer	0.00255	0.00383	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00253	0.00381	CcSEcCtD
Estazolam—Headache—Sorafenib—liver cancer	0.00253	0.00381	CcSEcCtD
Estazolam—Nasopharyngitis—Doxorubicin—liver cancer	0.00252	0.00378	CcSEcCtD
Estazolam—Gastritis—Doxorubicin—liver cancer	0.00249	0.00374	CcSEcCtD
Estazolam—Asthma—Doxorubicin—liver cancer	0.00243	0.00365	CcSEcCtD
Estazolam—Pollakiuria—Epirubicin—liver cancer	0.00243	0.00365	CcSEcCtD
Estazolam—Nausea—Sorafenib—liver cancer	0.0024	0.00361	CcSEcCtD
Estazolam—Photosensitivity reaction—Epirubicin—liver cancer	0.0024	0.00361	CcSEcCtD
Estazolam—Weight increased—Epirubicin—liver cancer	0.00239	0.00359	CcSEcCtD
Estazolam—Weight decreased—Epirubicin—liver cancer	0.00238	0.00357	CcSEcCtD
Estazolam—Clonazepam—CYP2E1—liver cancer	0.00236	0.108	CrCbGaD
Estazolam—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00232	0.00349	CcSEcCtD
Estazolam—Neuropathy peripheral—Epirubicin—liver cancer	0.0023	0.00345	CcSEcCtD
Estazolam—Sweating—Epirubicin—liver cancer	0.00225	0.00338	CcSEcCtD
Estazolam—Pollakiuria—Doxorubicin—liver cancer	0.00225	0.00338	CcSEcCtD
Estazolam—Haematuria—Epirubicin—liver cancer	0.00224	0.00336	CcSEcCtD
Estazolam—Photosensitivity reaction—Doxorubicin—liver cancer	0.00222	0.00334	CcSEcCtD
Estazolam—Weight increased—Doxorubicin—liver cancer	0.00221	0.00333	CcSEcCtD
Estazolam—Epistaxis—Epirubicin—liver cancer	0.00221	0.00332	CcSEcCtD
Estazolam—Weight decreased—Doxorubicin—liver cancer	0.0022	0.00331	CcSEcCtD
Estazolam—Sinusitis—Epirubicin—liver cancer	0.0022	0.0033	CcSEcCtD
Estazolam—Agranulocytosis—Epirubicin—liver cancer	0.00219	0.00329	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00215	0.00323	CcSEcCtD
Estazolam—Neuropathy peripheral—Doxorubicin—liver cancer	0.00213	0.00319	CcSEcCtD
Estazolam—Rhinitis—Epirubicin—liver cancer	0.00211	0.00317	CcSEcCtD
Estazolam—Pharyngitis—Epirubicin—liver cancer	0.00209	0.00314	CcSEcCtD
Estazolam—Sweating—Doxorubicin—liver cancer	0.00208	0.00312	CcSEcCtD
Estazolam—Haematuria—Doxorubicin—liver cancer	0.00207	0.00311	CcSEcCtD
Estazolam—Epistaxis—Doxorubicin—liver cancer	0.00205	0.00307	CcSEcCtD
Estazolam—Sinusitis—Doxorubicin—liver cancer	0.00204	0.00306	CcSEcCtD
Estazolam—Visual impairment—Epirubicin—liver cancer	0.00203	0.00305	CcSEcCtD
Estazolam—Agranulocytosis—Doxorubicin—liver cancer	0.00202	0.00304	CcSEcCtD
Estazolam—Erythema multiforme—Epirubicin—liver cancer	0.00199	0.00299	CcSEcCtD
Estazolam—Tinnitus—Epirubicin—liver cancer	0.00196	0.00295	CcSEcCtD
Estazolam—Flushing—Epirubicin—liver cancer	0.00195	0.00293	CcSEcCtD
Estazolam—Rhinitis—Doxorubicin—liver cancer	0.00195	0.00293	CcSEcCtD
Estazolam—Pharyngitis—Doxorubicin—liver cancer	0.00193	0.0029	CcSEcCtD
Estazolam—Flunitrazepam—CYP2E1—liver cancer	0.00189	0.0866	CrCbGaD
Estazolam—Chills—Epirubicin—liver cancer	0.00189	0.00284	CcSEcCtD
Estazolam—Arrhythmia—Epirubicin—liver cancer	0.00188	0.00282	CcSEcCtD
Estazolam—Visual impairment—Doxorubicin—liver cancer	0.00188	0.00282	CcSEcCtD
Estazolam—Erythema multiforme—Doxorubicin—liver cancer	0.00184	0.00277	CcSEcCtD
Estazolam—Malnutrition—Epirubicin—liver cancer	0.00183	0.00275	CcSEcCtD
Estazolam—Tinnitus—Doxorubicin—liver cancer	0.00182	0.00273	CcSEcCtD
Estazolam—Flushing—Doxorubicin—liver cancer	0.00181	0.00272	CcSEcCtD
Estazolam—Flatulence—Epirubicin—liver cancer	0.00181	0.00271	CcSEcCtD
Estazolam—Tension—Epirubicin—liver cancer	0.0018	0.0027	CcSEcCtD
Estazolam—Nervousness—Epirubicin—liver cancer	0.00178	0.00267	CcSEcCtD
Estazolam—Back pain—Epirubicin—liver cancer	0.00177	0.00266	CcSEcCtD
Estazolam—Muscle spasms—Epirubicin—liver cancer	0.00176	0.00265	CcSEcCtD
Estazolam—Chills—Doxorubicin—liver cancer	0.00175	0.00263	CcSEcCtD
Estazolam—Arrhythmia—Doxorubicin—liver cancer	0.00174	0.00261	CcSEcCtD
Estazolam—Nitrazepam—CYP2E1—liver cancer	0.00171	0.0782	CrCbGaD
Estazolam—Ill-defined disorder—Epirubicin—liver cancer	0.0017	0.00255	CcSEcCtD
Estazolam—Malnutrition—Doxorubicin—liver cancer	0.0017	0.00255	CcSEcCtD
Estazolam—Agitation—Epirubicin—liver cancer	0.00168	0.00253	CcSEcCtD
Estazolam—Flatulence—Doxorubicin—liver cancer	0.00167	0.00251	CcSEcCtD
Estazolam—Tension—Doxorubicin—liver cancer	0.00166	0.0025	CcSEcCtD
Estazolam—Malaise—Epirubicin—liver cancer	0.00165	0.00248	CcSEcCtD
Estazolam—Nervousness—Doxorubicin—liver cancer	0.00165	0.00247	CcSEcCtD
Estazolam—Syncope—Epirubicin—liver cancer	0.00164	0.00247	CcSEcCtD
Estazolam—Leukopenia—Epirubicin—liver cancer	0.00164	0.00246	CcSEcCtD
Estazolam—Back pain—Doxorubicin—liver cancer	0.00164	0.00246	CcSEcCtD
Estazolam—Muscle spasms—Doxorubicin—liver cancer	0.00163	0.00245	CcSEcCtD
Estazolam—Palpitations—Epirubicin—liver cancer	0.00162	0.00243	CcSEcCtD
Estazolam—Loss of consciousness—Epirubicin—liver cancer	0.00161	0.00242	CcSEcCtD
Estazolam—Ketazolam—ALB—liver cancer	0.00161	0.0735	CrCbGaD
Estazolam—Cough—Epirubicin—liver cancer	0.0016	0.0024	CcSEcCtD
Estazolam—Convulsion—Epirubicin—liver cancer	0.00159	0.00238	CcSEcCtD
Estazolam—Ill-defined disorder—Doxorubicin—liver cancer	0.00157	0.00236	CcSEcCtD
Estazolam—Arthralgia—Epirubicin—liver cancer	0.00156	0.00234	CcSEcCtD
Estazolam—Chest pain—Epirubicin—liver cancer	0.00156	0.00234	CcSEcCtD
Estazolam—Myalgia—Epirubicin—liver cancer	0.00156	0.00234	CcSEcCtD
Estazolam—Agitation—Doxorubicin—liver cancer	0.00156	0.00234	CcSEcCtD
Estazolam—Anxiety—Epirubicin—liver cancer	0.00155	0.00234	CcSEcCtD
Estazolam—Discomfort—Epirubicin—liver cancer	0.00154	0.00232	CcSEcCtD
Estazolam—Malaise—Doxorubicin—liver cancer	0.00153	0.0023	CcSEcCtD
Estazolam—Dry mouth—Epirubicin—liver cancer	0.00153	0.00229	CcSEcCtD
Estazolam—Syncope—Doxorubicin—liver cancer	0.00152	0.00228	CcSEcCtD
Estazolam—Flurazepam—CYP2E1—liver cancer	0.00152	0.0695	CrCbGaD
Estazolam—Leukopenia—Doxorubicin—liver cancer	0.00152	0.00228	CcSEcCtD
Estazolam—Confusional state—Epirubicin—liver cancer	0.00151	0.00226	CcSEcCtD
Estazolam—Palpitations—Doxorubicin—liver cancer	0.0015	0.00225	CcSEcCtD
Estazolam—Oedema—Epirubicin—liver cancer	0.0015	0.00225	CcSEcCtD
Estazolam—Loss of consciousness—Doxorubicin—liver cancer	0.00149	0.00224	CcSEcCtD
Estazolam—Cough—Doxorubicin—liver cancer	0.00148	0.00222	CcSEcCtD
Estazolam—Shock—Epirubicin—liver cancer	0.00147	0.00221	CcSEcCtD
Estazolam—Convulsion—Doxorubicin—liver cancer	0.00147	0.00221	CcSEcCtD
Estazolam—Hyperhidrosis—Epirubicin—liver cancer	0.00145	0.00217	CcSEcCtD
Estazolam—Arthralgia—Doxorubicin—liver cancer	0.00144	0.00217	CcSEcCtD
Estazolam—Chest pain—Doxorubicin—liver cancer	0.00144	0.00217	CcSEcCtD
Estazolam—Myalgia—Doxorubicin—liver cancer	0.00144	0.00217	CcSEcCtD
Estazolam—Anxiety—Doxorubicin—liver cancer	0.00144	0.00216	CcSEcCtD
Estazolam—Discomfort—Doxorubicin—liver cancer	0.00143	0.00214	CcSEcCtD
Estazolam—Dry mouth—Doxorubicin—liver cancer	0.00141	0.00212	CcSEcCtD
Estazolam—Midazolam—CYP2E1—liver cancer	0.00141	0.0644	CrCbGaD
Estazolam—Confusional state—Doxorubicin—liver cancer	0.0014	0.0021	CcSEcCtD
Estazolam—Oedema—Doxorubicin—liver cancer	0.00138	0.00208	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00136	0.00205	CcSEcCtD
Estazolam—Shock—Doxorubicin—liver cancer	0.00136	0.00204	CcSEcCtD
Estazolam—Paraesthesia—Epirubicin—liver cancer	0.00134	0.00202	CcSEcCtD
Estazolam—Hyperhidrosis—Doxorubicin—liver cancer	0.00134	0.00201	CcSEcCtD
Estazolam—Dyspnoea—Epirubicin—liver cancer	0.00133	0.002	CcSEcCtD
Estazolam—Somnolence—Epirubicin—liver cancer	0.00133	0.002	CcSEcCtD
Estazolam—Dyspepsia—Epirubicin—liver cancer	0.00132	0.00198	CcSEcCtD
Estazolam—Decreased appetite—Epirubicin—liver cancer	0.0013	0.00195	CcSEcCtD
Estazolam—Clonazepam—ALB—liver cancer	0.00129	0.0593	CrCbGaD
Estazolam—Pain—Epirubicin—liver cancer	0.00128	0.00192	CcSEcCtD
Estazolam—Constipation—Epirubicin—liver cancer	0.00128	0.00192	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00126	0.00189	CcSEcCtD
Estazolam—Paraesthesia—Doxorubicin—liver cancer	0.00124	0.00187	CcSEcCtD
Estazolam—Dyspnoea—Doxorubicin—liver cancer	0.00123	0.00185	CcSEcCtD
Estazolam—Feeling abnormal—Epirubicin—liver cancer	0.00123	0.00185	CcSEcCtD
Estazolam—Somnolence—Doxorubicin—liver cancer	0.00123	0.00185	CcSEcCtD
Estazolam—Gastrointestinal pain—Epirubicin—liver cancer	0.00122	0.00184	CcSEcCtD
Estazolam—Dyspepsia—Doxorubicin—liver cancer	0.00122	0.00183	CcSEcCtD
Estazolam—Diazepam—CYP2E1—liver cancer	0.00121	0.0552	CrCbGaD
Estazolam—Decreased appetite—Doxorubicin—liver cancer	0.0012	0.00181	CcSEcCtD
Estazolam—Urticaria—Epirubicin—liver cancer	0.00119	0.00178	CcSEcCtD
Estazolam—Pain—Doxorubicin—liver cancer	0.00118	0.00178	CcSEcCtD
Estazolam—Constipation—Doxorubicin—liver cancer	0.00118	0.00178	CcSEcCtD
Estazolam—Abdominal pain—Epirubicin—liver cancer	0.00118	0.00178	CcSEcCtD
Estazolam—Body temperature increased—Epirubicin—liver cancer	0.00118	0.00178	CcSEcCtD
Estazolam—Feeling abnormal—Doxorubicin—liver cancer	0.00114	0.00171	CcSEcCtD
Estazolam—Gastrointestinal pain—Doxorubicin—liver cancer	0.00113	0.0017	CcSEcCtD
Estazolam—Hypersensitivity—Epirubicin—liver cancer	0.0011	0.00166	CcSEcCtD
Estazolam—Urticaria—Doxorubicin—liver cancer	0.0011	0.00165	CcSEcCtD
Estazolam—Abdominal pain—Doxorubicin—liver cancer	0.00109	0.00164	CcSEcCtD
Estazolam—Body temperature increased—Doxorubicin—liver cancer	0.00109	0.00164	CcSEcCtD
Estazolam—Asthenia—Epirubicin—liver cancer	0.00107	0.00161	CcSEcCtD
Estazolam—Pruritus—Epirubicin—liver cancer	0.00106	0.00159	CcSEcCtD
Estazolam—Hypersensitivity—Doxorubicin—liver cancer	0.00102	0.00153	CcSEcCtD
Estazolam—Asthenia—Doxorubicin—liver cancer	0.000993	0.00149	CcSEcCtD
Estazolam—Dizziness—Epirubicin—liver cancer	0.000989	0.00149	CcSEcCtD
Estazolam—Pruritus—Doxorubicin—liver cancer	0.000979	0.00147	CcSEcCtD
Estazolam—Vomiting—Epirubicin—liver cancer	0.000951	0.00143	CcSEcCtD
Estazolam—Rash—Epirubicin—liver cancer	0.000943	0.00142	CcSEcCtD
Estazolam—Dermatitis—Epirubicin—liver cancer	0.000942	0.00142	CcSEcCtD
Estazolam—Headache—Epirubicin—liver cancer	0.000937	0.00141	CcSEcCtD
Estazolam—Dizziness—Doxorubicin—liver cancer	0.000915	0.00137	CcSEcCtD
Estazolam—Nausea—Epirubicin—liver cancer	0.000888	0.00133	CcSEcCtD
Estazolam—Vomiting—Doxorubicin—liver cancer	0.00088	0.00132	CcSEcCtD
Estazolam—Rash—Doxorubicin—liver cancer	0.000872	0.00131	CcSEcCtD
Estazolam—Dermatitis—Doxorubicin—liver cancer	0.000872	0.00131	CcSEcCtD
Estazolam—Headache—Doxorubicin—liver cancer	0.000867	0.0013	CcSEcCtD
Estazolam—Nausea—Doxorubicin—liver cancer	0.000822	0.00123	CcSEcCtD
Estazolam—Diazepam—ALB—liver cancer	0.000662	0.0303	CrCbGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000526	0.00168	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000522	0.00167	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000522	0.00167	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MAPK14—liver cancer	0.000515	0.00165	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000515	0.00165	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000513	0.00164	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000513	0.00164	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000506	0.00162	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000497	0.00159	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000494	0.00158	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000493	0.00158	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00049	0.00157	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000489	0.00157	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000485	0.00155	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000482	0.00154	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000479	0.00153	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—APC—liver cancer	0.000478	0.00153	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000471	0.00151	CbGpPWpGaD
Estazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00047	0.0015	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000468	0.0015	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000468	0.0015	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000463	0.00148	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.00046	0.00147	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000454	0.00145	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000451	0.00144	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000448	0.00143	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000448	0.00143	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000448	0.00143	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000447	0.00143	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—BRAF—liver cancer	0.000441	0.00141	CbGpPWpGaD
Estazolam—GABRG3—Ion channel transport—RAF1—liver cancer	0.000435	0.00139	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000434	0.00139	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—BRAF—liver cancer	0.00043	0.00138	CbGpPWpGaD
Estazolam—GABRB1—Ion channel transport—RAF1—liver cancer	0.000429	0.00137	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000424	0.00136	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000412	0.00132	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—BRAF—liver cancer	0.00041	0.00131	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000409	0.00131	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000403	0.00129	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.0004	0.00128	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000394	0.00126	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000393	0.00126	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—CYCS—liver cancer	0.00039	0.00125	CbGpPWpGaD
Estazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000388	0.00124	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000386	0.00124	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000384	0.00123	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000377	0.00121	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—RAF1—liver cancer	0.000375	0.0012	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000371	0.00119	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000368	0.00118	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000368	0.00118	CbGpPWpGaD
Estazolam—GABRB2—Ion channel transport—RAF1—liver cancer	0.000367	0.00117	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MTOR—liver cancer	0.000366	0.00117	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000362	0.00116	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—BRAF—liver cancer	0.00036	0.00115	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—RAF1—liver cancer	0.000359	0.00115	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000359	0.00115	CbGpPWpGaD
Estazolam—GABRA5—Ion channel transport—RAF1—liver cancer	0.000356	0.00114	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000355	0.00114	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—BRAF—liver cancer	0.000354	0.00113	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000353	0.00113	CbGpPWpGaD
Estazolam—GABRA3—Ion channel transport—RAF1—liver cancer	0.00035	0.00112	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000348	0.00111	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000348	0.00111	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—BRAF—liver cancer	0.000345	0.00111	CbGpPWpGaD
Estazolam—GABRA2—Ion channel transport—RAF1—liver cancer	0.000344	0.0011	CbGpPWpGaD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000343	0.0011	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—RAF1—liver cancer	0.000342	0.0011	CbGpPWpGaD
Estazolam—GABRB3—Ion channel transport—RAF1—liver cancer	0.000341	0.00109	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000339	0.00109	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000339	0.00108	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—BRAF—liver cancer	0.000338	0.00108	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CASP3—liver cancer	0.000337	0.00108	CbGpPWpGaD
Estazolam—GABRG2—Ion channel transport—RAF1—liver cancer	0.000335	0.00107	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—BRAF—liver cancer	0.000333	0.00106	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000329	0.00105	CbGpPWpGaD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000327	0.00105	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—JUN—liver cancer	0.000327	0.00105	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000326	0.00104	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CTNNB1—liver cancer	0.000325	0.00104	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000323	0.00103	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000322	0.00103	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000321	0.00103	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000318	0.00102	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000316	0.00101	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000314	0.00101	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—RAF1—liver cancer	0.00031	0.000991	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MAPK8—liver cancer	0.00031	0.000991	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000303	0.000971	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—RAF1—liver cancer	0.000301	0.000963	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—NAT2—liver cancer	0.0003	0.00096	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000297	0.000949	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000296	0.000946	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000295	0.000945	CbGpPWpGaD
Estazolam—GABRA1—Ion channel transport—RAF1—liver cancer	0.000293	0.000938	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—RAF1—liver cancer	0.00029	0.000929	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000288	0.000923	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000287	0.000919	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—BRAF—liver cancer	0.000284	0.000909	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000283	0.000906	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—STAT3—liver cancer	0.000283	0.000906	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—RAF1—liver cancer	0.000282	0.000902	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000279	0.000893	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—RAF1—liver cancer	0.000278	0.000889	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—BRAF—liver cancer	0.000276	0.000883	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000275	0.00088	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000274	0.000876	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000271	0.000868	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—BRAF—liver cancer	0.000271	0.000868	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—CYCS—liver cancer	0.00027	0.000865	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000269	0.000862	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—BRAF—liver cancer	0.000266	0.000853	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000265	0.000849	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—BRAF—liver cancer	0.000265	0.000847	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000264	0.000846	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000263	0.000843	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—CYCS—liver cancer	0.000263	0.00084	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000261	0.000837	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—BRAF—liver cancer	0.00026	0.000832	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000258	0.000825	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000258	0.000825	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000253	0.000811	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000252	0.000806	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000251	0.000805	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000248	0.000792	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000247	0.000791	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000246	0.000787	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.00024	0.000767	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—RAF1—liver cancer	0.000237	0.000759	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000235	0.000752	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—RAF1—liver cancer	0.000231	0.000738	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.00023	0.000736	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000228	0.00073	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—BRAF—liver cancer	0.000227	0.000727	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000227	0.000726	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—RAF1—liver cancer	0.000226	0.000724	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000226	0.000722	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000224	0.000717	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—RAF1—liver cancer	0.000222	0.000712	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000222	0.000711	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—RAF1—liver cancer	0.000221	0.000707	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.00022	0.000705	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00022	0.000705	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000219	0.0007	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—RAF1—liver cancer	0.000217	0.000694	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000216	0.000692	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000216	0.000691	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000215	0.000688	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ALB—liver cancer	0.000213	0.000683	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000213	0.000681	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000211	0.000676	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000207	0.000664	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—HRAS—liver cancer	0.000207	0.000661	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ALB—liver cancer	0.000204	0.000651	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000203	0.000648	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—HRAS—liver cancer	0.0002	0.000639	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—HRAS—liver cancer	0.000198	0.000632	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000197	0.000631	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000195	0.000625	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000193	0.000617	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000193	0.000617	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—PPARA—liver cancer	0.00019	0.000607	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—RAF1—liver cancer	0.00019	0.000607	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—HRAS—liver cancer	0.000189	0.000603	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000188	0.000601	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—PPARA—liver cancer	0.000184	0.00059	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000184	0.000589	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—AKT1—liver cancer	0.000182	0.000584	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000181	0.00058	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000181	0.000579	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000179	0.000574	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000178	0.000569	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000177	0.000566	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000174	0.000556	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000171	0.000546	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ALB—liver cancer	0.000168	0.000536	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—HRAS—liver cancer	0.000166	0.00053	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ALB—liver cancer	0.000165	0.000528	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000163	0.000521	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000161	0.000516	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—HRAS—liver cancer	0.00016	0.000512	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000159	0.000509	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000159	0.000509	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000159	0.000508	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000156	0.000499	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—HRAS—liver cancer	0.000155	0.000497	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—HRAS—liver cancer	0.000153	0.000489	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000152	0.000486	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000152	0.000485	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000149	0.000478	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000148	0.000474	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000146	0.000467	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ALB—liver cancer	0.000141	0.000451	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.00014	0.000449	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000138	0.000443	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ALB—liver cancer	0.000137	0.000439	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000136	0.000436	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ALB—liver cancer	0.000135	0.000431	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	0.000132	0.000423	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ALB—liver cancer	0.000131	0.00042	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—HRAS—liver cancer	0.000131	0.000418	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	0.000129	0.000413	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000128	0.000408	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—HRAS—liver cancer	0.000127	0.000406	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—HRAS—liver cancer	0.000125	0.000399	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—RAF1—liver cancer	0.000124	0.000397	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—HRAS—liver cancer	0.000122	0.000392	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000122	0.000389	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—HRAS—liver cancer	0.000122	0.000389	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	0.00012	0.000383	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—HRAS—liver cancer	0.00012	0.000382	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000119	0.00038	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000117	0.000373	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	0.000113	0.000361	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UGDH—liver cancer	0.000105	0.000336	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—HRAS—liver cancer	0.000104	0.000334	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000102	0.000326	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—EPT1—liver cancer	9.87e-05	0.000316	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TAT—liver cancer	9.36e-05	0.0003	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CPT1B—liver cancer	6.36e-05	0.000204	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GLUL—liver cancer	6.36e-05	0.000204	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NR1H4—liver cancer	6.14e-05	0.000196	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA3—liver cancer	6.03e-05	0.000193	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA4—liver cancer	5.52e-05	0.000177	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA2—liver cancer	5.38e-05	0.000172	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA1—liver cancer	5.19e-05	0.000166	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NAT2—liver cancer	5.13e-05	0.000164	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALDOB—liver cancer	4.92e-05	0.000157	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CRABP1—liver cancer	4.69e-05	0.00015	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HPGDS—liver cancer	4.1e-05	0.000131	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PSMA4—liver cancer	3.65e-05	0.000117	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PSMD10—liver cancer	3.65e-05	0.000117	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GOT2—liver cancer	3.55e-05	0.000114	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2E1—liver cancer	3.34e-05	0.000107	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYCS—liver cancer	3.13e-05	0.0001	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GGT1—liver cancer	3.07e-05	9.82e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GOT1—liver cancer	3.07e-05	9.82e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTP1—liver cancer	2.76e-05	8.82e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HMOX1—liver cancer	2.72e-05	8.7e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTM1—liver cancer	2.53e-05	8.11e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP1A1—liver cancer	2.4e-05	7.68e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTHFR—liver cancer	2.24e-05	7.16e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PPARA—liver cancer	2.2e-05	7.03e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CG—liver cancer	1.88e-05	6.02e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PPARG—liver cancer	1.82e-05	5.81e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CD—liver cancer	1.65e-05	5.29e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALB—liver cancer	1.63e-05	5.22e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CB—liver cancer	1.44e-05	4.61e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CA—liver cancer	8.79e-06	2.81e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKT1—liver cancer	7.18e-06	2.3e-05	CbGpPWpGaD
